THE WHY HOW DO COMPANY, Inc. Logo

THE WHY HOW DO COMPANY, Inc.

A corporate regeneration platform for business turnarounds, M&A, and succession solutions.

3823 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
新宿区愛住町22
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

THE WHY HOW DO COMPANY, Inc. operates a multifaceted 'corporate regeneration platform' focused on fostering mutual growth for companies and their personnel. The company's strategic business model centers on three core areas: conventional business turnarounds, innovative 'non-sale business succession' solutions, and functioning as a 'business model general trading company.' Through these services, it aims to establish a unique position as a comprehensive developer within the M&A industry, prioritizing value creation and sustainable growth. Historically known as Acrodea Inc., its operations also encompass software development, IoT solutions, and entertainment-related businesses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-16 09:08
Board/Management Information
臨時報告書
Japanese 21.7 KB
2025-07-14 09:46
Legal Proceedings Report
臨時報告書
Japanese 18.9 KB
2025-05-27 09:37
Board/Management Information
臨時報告書
Japanese 19.4 KB
2025-04-14 08:49
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-04-14 08:47
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-04-14 08:45
Interim Report
半期報告書-第21期(2024/09/01-2025/08/31)
Japanese 294.3 KB
2025-01-29 07:42
Regulatory News Service
臨時報告書
Japanese 18.3 KB
2025-01-14 08:09
Regulatory News Service
臨時報告書
Japanese 19.4 KB
2024-11-29 08:43
Post-Annual General Meeting Information
臨時報告書
Japanese 20.1 KB
2024-11-29 08:41
Registration Form
確認書
Japanese 8.1 KB
2024-11-29 08:40
Governance Information
内部統制報告書-第20期(2023/09/01-2024/08/31)
Japanese 25.1 KB
2024-11-29 08:37
Annual Report
有価証券報告書-第20期(2023/09/01-2024/08/31)
Japanese 1.3 MB
2024-11-13 07:32
Annual Report
訂正有価証券報告書-第15期(2018/09/01-2019/08/31)
Japanese 1.4 MB
2024-10-18 10:13
Regulatory News Service
臨時報告書
Japanese 20.9 KB
2024-08-15 08:22
Regulatory News Service
訂正有価証券報告書-第15期(2018/09/01-2019/08/31)
Japanese 675.6 KB

Automate Your Workflow. Get a real-time feed of all THE WHY HOW DO COMPANY, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for THE WHY HOW DO COMPANY, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CARTA HOLDINGS, INC. Logo
Digital marketing firm offering ad platforms and integrated solutions to empower businesses.
Japan 3688
Celyad Oncology SA Logo
Clinical-stage biotech developing CAR T therapies for solid and blood cancers.
Belgium CYAD
CENTAUR MEDIA PLC Logo
Provides business intelligence, learning, and consultancy for marketing & legal professionals.
United Kingdom CAU
Cereno Scientific AB Logo
Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.
Sweden CRNO
CERES INC. Logo
Develops online media platforms connecting consumers with advertisers through a rewards system.
Japan 3696
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.
South Korea 085660
An Ad-Tech firm providing digital marketing, SEO, social media, and creative ad solutions.
South Korea 351870
Ch. Charilaou Group Plc Logo
A tour operator selling travel packages and developing online reservation platform solutions.
Cyprus CHCH
Creates data-driven, integrated marketing and connected experiences for global brands.
South Korea 030000
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan 4583

Talk to a Data Expert

Have a question? We'll get back to you promptly.